Capture of circulating metastatic cancer cell clusters from lung cancer patients can reveal unique genomic profiles and potential anti-metastatic molecular targets: A …
K Kouhmareh, E Martin, D Finlay, A Bhadada… - Plos one, 2024 - journals.plos.org
Metastasis remains the leading cause of cancer deaths worldwide and lung cancer, known
for its highly metastatic progression, remains among the most lethal of malignancies. Lung …
for its highly metastatic progression, remains among the most lethal of malignancies. Lung …
[HTML][HTML] AGTR1: a potential biomarker associated with the occurrence and prognosis of lung adenocarcinoma
R Xiao, J Han, Y Deng, L Zhang, Y Qian… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction Lung adenocarcinoma, a disease with complex pathogenesis, high mortality
and poor prognosis, is one of the subtypes of lung cancer. Hence, it is very crucial to find …
and poor prognosis, is one of the subtypes of lung cancer. Hence, it is very crucial to find …
[HTML][HTML] Bioinformatics analysis of the prognostic role of alternative splicing data in lung adenocarcinoma
L Zhao, S He, Z Liu, Z Song, X Hou… - Journal of Thoracic …, 2024 - ncbi.nlm.nih.gov
Background As a post-transcriptional regulatory mechanism, alternative splicing (AS) is
engaged in a variety of pathophysiological processes, and it has been widely reported in …
engaged in a variety of pathophysiological processes, and it has been widely reported in …
[HTML][HTML] Molecular mechanism and clinical outcome of non-small cell lung cancer patients with high BRAF expression
Y Uehara - Translational Lung Cancer Research, 2023 - ncbi.nlm.nih.gov
Correspondence to: Yuji Uehara, MD. Department of Thoracic Oncology and Respiratory
Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital …
Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital …
Selective capture of circulating metastatic cancer cell clusters from lung cancer patients reveals a unique genomic profile that identifies anti-metastatic molecular …
K Kouhmareh, E Martin, D Finlay… - Biorxiv: the Preprint …, 2023 - europepmc.org
Metastasis remains the leading cause of cancer deaths worldwide. Lung cancer remains
lethal, known for its highly metastatic progression. The unknown genomic profile of …
lethal, known for its highly metastatic progression. The unknown genomic profile of …